WallStSmart

Ouster, Inc. Common Stock (OUST)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 53% more annual revenue ($258.90M vs $169.38M). ZEPP leads profitability with a -15.5% profit margin vs -35.6%. ZEPP earns a higher WallStSmart Score of 38/100 (F).

OUST

Avoid

25

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 6.0Quality: 7.0
Piotroski: 4/9Altman Z: -3.02

ZEPP

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

OUSTUndervalued (+29.8%)

Margin of Safety

+29.8%

Fair Value

$26.89

Current Price

$29.39

$2.50 discount

UndervaluedFair: $26.89Overvalued
ZEPPUndervalued (+48.9%)

Margin of Safety

+48.9%

Fair Value

$46.96

Current Price

$18.01

$28.95 discount

UndervaluedFair: $46.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

OUST2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
106.6%10/10

Revenue surging 106.6% year-over-year

Debt/EquityHealth
0.0610/10

Conservative balance sheet, low leverage

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

OUST4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.68B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-27.3%2/10

ROE of -27.3% — below average capital efficiency

Free Cash FlowQuality
$-37.18M2/10

Negative free cash flow — burning cash

ZEPP4 concerns · Avg: 2.3/10
Market CapQuality
$270.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Free Cash FlowQuality
$-26.48M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : OUST

The strongest argument for OUST centers on Revenue Growth, Debt/Equity. Revenue growth of 106.6% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : OUST

The primary concerns for OUST are EPS Growth, Market Cap, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

OUST carries more volatility with a beta of 3.06 — expect wider price swings.

OUST is growing revenue faster at 106.6% — sustainability is the question.

ZEPP generates stronger free cash flow (-26M), providing more financial flexibility.

Monitor ELECTRONIC COMPONENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ZEPP scores higher overall (38/100 vs 25/100) and 43.0% revenue growth. OUST offers better value entry with a 29.8% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ouster, Inc. Common Stock

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

Ouster, Inc. designs and manufactures digital lidar sensors for the industrial automation, intelligent infrastructure, robotics and automotive markets. The company is headquartered in San Francisco, California.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?